JOSEF H VON RICKENBACH
CIK 1007706 · Chairman & CEO · last filed 2026-05-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$55.6K
Companies
4
Total Filings
102
Lifetime Open-Market Net
-$28.10M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNTX | Director | 58,014 | $0.96 | $55.6K | $49.6K | 2 | 2026-05-28 |
| Rein Therapeutics, Inc. (ALRN) Delisted | Director | 445,460 | $2.11 | $939.9K | $400.3K | 13 | 2024-12-06 |
| Virgin Orbit Holdings, Inc. (VORBW) Delisted | 125,000 | $0.01 | $875 | $0 | 1 | 2022-01-03 | |
| PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Chairman & CEO | 503,329 | — | — | -$28.55M | 85 | 2017-09-18 |
Recent Filings · Page 2 of 11
102 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-09 | Rein Therapeutics, Inc. (ALRN) Delisted | Buy (P) | +227,272 | $250.0K | EDGAR |
| 2019-09-16 | Rein Therapeutics, Inc. (ALRN) Delisted | Buy (P) | +113,145 | $110.5K | EDGAR |
| 2019-09-05 | Rein Therapeutics, Inc. (ALRN) Delisted | Buy (P) | +23,225 | $16.6K | EDGAR |
| 2019-09-04 | Rein Therapeutics, Inc. (ALRN) Delisted | Buy (P) | +28,466 | $20.4K | EDGAR |
| 2019-09-03 | Rein Therapeutics, Inc. (ALRN) Delisted | Buy (P) | +3,600 | $2.8K | EDGAR |
| 2019-06-24 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-04 | — | Mixed | −503,329 | $0 | |
| 2017-09-18 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Tax (F) | −4,642 | -$408.2K | EDGAR |
| 2017-09-12 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Mixed | −28,889 | -$1.35M | EDGAR |
| 2016-09-16 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Grant (A) | +29,600 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.